Figure Legends
Figure 1: The flow chart of study design and procedure. SA, sevelamer carbonate; CA: calcium acetate.
Figure 2: Changes in serum lipids after 12 weeks of treatment with sevelamer carbonate and calcium acetate. a) TC, total cholesterol, b) HDL-C, high-density-lipoprotein cholesterol, c) TG, triglycerides, d) LDL-C, low-density lipoprotein cholesterol. Mean ± SD *P <0.05, ***P <0.001 .
Figure 3: Changes in serum inflammatory markers after 12 weeks of treatment with sevelamer carbonate and calcium acetate. a) Interleukin-6, b) Interleukin-8, c) Interleukin-10, d) IFN-γ, e) TNF-α. Values expressed as mean ± SD **P <0.01, ***P<0.001.
Figure 4: a) ICAM-1, b) VCAM-1, c) P-selectin, d) E-selectin, e) L-selectin. Values expressed as mean ± SD *P <0.05, **P <0.01.